期刊文献+

宫颈病变中人乳头瘤病毒感染特征分析 被引量:4

Analysis the prevalence and type distribution of human papillomavirus in cervical lesions
下载PDF
导出
摘要 目的探讨人乳头瘤病毒(HPV)在妇女宫颈病变中的型别分布特征及感染特点。方法收集2009~2011年1 213例宫颈病变活检组织标本(CINⅠ317例,CINⅡ233例,CINⅢ208例,宫颈鳞状细胞癌198例,慢性宫颈炎257例),采用PCR-反向点杂交法进行HPV DNA分型检测。结果 HPV在女性宫颈病变中的平均感染率为69.74%,随着病变严重程度的增加HPV感染率亦增加,二者呈正相关(P<0.05)。各组病变中以HPV16的感染率最高,其次为HPV58、18、33、11。CINⅠ组中感染最多的前3位为HPV16、58、11;CINⅡ组中感染最多的前3位为HPV16、58、33;CINⅢ组中感染最多的前3位为HPV16、58、18;SCC组中感染最多的前3位为HPV16、18、58;宫颈炎组中感染最多的前3位为HPV16、58、33。每组病变都存在单纯感染和复合感染,复合感染随着病变严重程度的增加而减少。结论 HPV的感染率及型别分布在不同病变的宫颈组织中均有一定的差异,致癌性肯定的HPV亚型中感染率较高的为HPV16、18和58。 Objective To explore the prevalence and subtype distribution of human papillomavirus(HPV) in cervical lesions.Methods From 2009 to 2011,1213 specimens,included 257 cases of chronic cervicitis,758 cases of CIN,and 198 cases of cervical squamous cell carcinoma(SCC),were collected for this study.PCR-reverse dot blot was adopted for HPV-DNA testing.Results The positive rate of HPV was 69.74% and was increased along with the severity of cervical lesions in all cases.The HPV l6 was the most common subtype,followed by HPV58、18、33、11.The top three HPV subtype were HPV16、58、11 in CIN Ⅰ group,were HPV16、58、33 in CIN Ⅱ group,were HPV16、58、18 in CIN Ⅲ group,were HPV16、18、58 in SCC group and were HPV16、58、33 in chronic cervicitis group.Single and composite infection were in all groups.The rate of composite infection was negatively correlated with the degree of cervical lesions.Conclusion HPV infection rate and distribution vary in various lesions of cervical tissue.HPV 16,18 and 58 were the most common types in carcinogenic HPV genotypes.
出处 《国际检验医学杂志》 CAS 2013年第14期1796-1797,1800,共3页 International Journal of Laboratory Medicine
关键词 乳头状瘤病毒感染 宫颈疾病 聚合酶链反应 papillomavirus infections uterine cervical diseases polymerase chain reaction
  • 相关文献

参考文献7

  • 1Shastri SS, Dinshaw K, Amin G, et al. Concurrent evaluation ofvisual, cytological and HPV testing as screening methods for theearly detection of cervical neoplasia in Mumbai,India[J]. BullWorld Health Organ,2005 ,83 : 186-194.
  • 2Castle PE. The evolving definition of carcinogenic human papillo-mavirus[J]. Infect Agent Cancer,2009,11(4) :7.
  • 3Siegel R,Naishadham D, Jemal A. Cancer statistics,2012[J]. CACancer J Clin,2012,62: 10-29.
  • 4Bouvard V, Baan R, Straif K, et al. A review of human carcino-gens-Part B: biological agents[J]. Lancet Oncol,2009 ,10(2) : 321-322.
  • 5Arbyn M, Kyrgiou M,Simoens C,et al. Perinatal mortality andother severe adverse pregnancy outcomes associated with treat-ment of cervical intraepithelial neoplasia: meta — analysis [J].BMJ,2008,18(337) :al284.
  • 6Cervical Pathology, and American Society for Clinical Pathologyscreening guidelines for the prevention and early detection of cer-vical cancer[J]. CA Cancer J Clin,2012,62(3) : 147-172.
  • 7Saslow D,Solomon D,Lawson HW,et al. American Cancer Soci-ety. American Society for Colposcopy and Cervical Pathology,and American Society for Clinical Pathology screening guidelinesfor the prevention and early detection of cervical cancer[J]. CACancer J Clin, 2012,62(3):147-172.

同被引文献43

  • 1陶萍萍,卞美璐,李敏,刘军.HPV多重感染与宫颈病变关系探讨[J].中国妇产科临床杂志,2006,7(2):94-96. 被引量:112
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [J]. CA Cancer J Clin, 2012, 62:10-29.
  • 3Cervival Pathology, and American Society for Clinnical Pathology screening guidelines for the prevention and early detection of cervical cancer[J]. CA Cancer J Clin, 2012, 62 (3): 147-172.
  • 4Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and Ameri- can Society for Clinical Pathology screening guidelines for the preven- tion and early detection of cervical cancer[J]. CA Cancer J Clin, 2012, 62(3):147-172.
  • 5马丁,奚玲.宫颈癌流行病学及病因学研究[J].中华妇产科杂志,2011,17(1):61.
  • 6Lehtinen M,Paavonen J,Wheeler CM,et al.Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia:4-year end-of-study analysis of the randomised,double-blind PATRICIA trial[J].The Lancet Oncology,2012,13(1):89-99.
  • 7Belinson JL,Du H,Yang B,et al.Improved sensitivity of vaginal self-collection and hish-risk Human papillomavims testing[J].Int J Cancer,2012,130(8):1855-1860.
  • 8Rijkaart DC,Berkhof J,Rozendaal L,et al.Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer:final results of the POBASCAM randomised controlled trial[J].The lancet oncology,2012,13(1):78-88.
  • 9陈占国,周武,许张晔,戴美洁,陶志华.导流杂交方法检测人乳头状瘤病毒分型的临床应用[J].中华医院感染学杂志,2008,18(9):1345-1348. 被引量:40
  • 10江敬红,张蔚,王卓然,易跃雄,苏钰,李金芯.HPV亚型在宫颈疾病中的分布特点[J].现代妇产科进展,2009,18(10):758-761. 被引量:16

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部